Zoology

NTT Research Develops Closed-Loop Control of Innervated Tissue

Retrieved on: 
Wednesday, November 2, 2022
Research, Technology, Neurology, Other Technology, Health Technology, Cardiology, Biometrics, Biotechnology, Health, Science, DRS, Leg, Goal, Name, Photonics, Migratory locust, Time-invariant system, Biomedical engineering, Peripheral nervous system, TUM, Research, Neurotechnology, MIBE, NTT, Harvard University, Silicon, Medicine, Department, Applied physics, Scientific Reports, Comenius University Faculty of Mathematics, Physics and Informatics, View, The Lab, NCVC, Ireland national cerebral palsy football team, Cryptography, Department of Zoology, University of Oxford, PHI, Doctor of Philosophy, Institute of technology, Nature, Lab, Electrode, Biomedicine, Technical University of Munich, Information, Neuroscience, Physics, Nippon Telegraph and Telephone, MEI, Movement, CIS, Mobile phone, Medical device, Engineering, Informatics, Zoology

NTT Research, Inc. , a division of NTT (TYO:9432), today announced that the collaboration between its Medical & Health Informatics (MEI) Lab and the Technical University of Munich (TUM) has produced a novel technique for closed-loop control of innervated tissue of a live insect.

Key Points: 
  • NTT Research, Inc. , a division of NTT (TYO:9432), today announced that the collaboration between its Medical & Health Informatics (MEI) Lab and the Technical University of Munich (TUM) has produced a novel technique for closed-loop control of innervated tissue of a live insect.
  • This work is part of a joint research program between TUM and NTT Research.
  • In June 2020, NTT Research opened an office in Munich in support of the joint research.
  • NTT Research is part of NTT, a global technology and business solutions provider with an annual R&D budget of $3.6 billion.

Protagonist Announces Appointment of Arturo Molina, M.D., M.S., F.A.C.P. as Chief Medical Officer

Retrieved on: 
Wednesday, November 2, 2022
Security (finance), Biotechnology, Risk, U.S. Securities and Exchange Commission, Lead, Health, Zoology, Division, Inflammatory bowel disease, Polycythemia, Industry, Janssen, COVID-19, Medicine, Department, Johnson & Johnson, Research, View, Stanford University Medical Center, Form 10-K, Form, Psychology, Physiology, University, Stanford University School of Medicine, Private Securities Litigation Reform Act, Company, Therapy, City, Janssen Biotech, Psoriasis, Patient, Multimedia, VERIFY, Forward-looking statement, Moses Austin, Pharmaceutical industry, Online shopping, Protagonist

NEWARK, Calif., Nov. 2, 2022 /PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced the appointment of Arturo Molina, M.D., M.S., F.A.C.P. to the role of Chief Medical Officer, effective November 7, 2022.

Key Points: 
  • to the role of Chief Medical Officer, effective November 7, 2022.
  • "We are extremely pleased to welcome Dr. Molina to Protagonist as our Chief Medical Officer," said Dinesh V. Patel, Ph.D., President and Chief Executive Officer of Protagonist.
  • Dr. Molina joins Protagonist from Sutro Biopharma, where he was Chief Medical Officer since 2016.
  • Earlier in his career, Dr. Molina was Chief Medical Officer at Cougar Biotechnology, acquired by Johnson & Johnson in 2009.

Lion Cub-Petting Study Finds Alarming Welfare Concerns in Animal Tourism Industry

Retrieved on: 
Thursday, October 27, 2022
Human, Mother, MDPI, PAWS, Joe Exotic, Cubs, The Lion King, Assistant, Lion, Zoology, Student, Social media, Industry, National Cat Day, IUCN Red List, Aggression, Research, GLOBE, FOUR, Cat, Tourism, Farm, Environmental studies, YouTube, Tiger, Public, Health, Solution, Hunting, New York University, Animal

Published in the Special Tenth Anniversary Issue of Animals , the study addresses the problem of cub-petting tourism and the harm it inflicts on lions.

Key Points: 
  • Published in the Special Tenth Anniversary Issue of Animals , the study addresses the problem of cub-petting tourism and the harm it inflicts on lions.
  • As with other forms of tourism, selfie culture abounds in cub-petting and social media provides a unique source of animal behavior and welfare data.
  • Co-authors include two recent NYU Animal Studies and Environmental Studies graduates, as well as staff from the U.S. Office of FOUR PAWS International, the global animal welfare organization.
  • These issues have implications not only for the captive lion industry in South Africa but for the overall welfare and conservation of a species.

Global Animal Intestinal Health Market Report (2022 to 2027) - Growth, Trends, Covid-19 Impact, and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, September 16, 2022
Health, Veterinary, Other Health, Probiotic, American Feed Industry Association, Health, Organization, Safety, United States Department of Agriculture, Milk, Journal, Development, Dairy, Food, Poultry, Economics, Meat, Organisation for Economic Co-operation and Development controversy, BMC, NASS, Economic Research Service, Digestion, Growth, Medicine, Sustainability, USDA, Maintenance, National Agricultural Statistics Service, Food and Agriculture Organization, Tilapia, Cattle, Statistics, Association, Zoology, BioMed Central, Animal, Environmental impact of meat production, Economy, Livestock, Sheep, Dietary supplement, Aquaculture

Probiotics could be beneficial in the improvement of health and growth of livestock and fish.

Key Points: 
  • Probiotics could be beneficial in the improvement of health and growth of livestock and fish.
  • Another article published in BMC Zoology in April 2021 conferred that probiotics help increase the rate of digestion in animals.
  • A research study published in the journal of Aquaculture in 2021 studied the effects of probiotics on the fish Tilapia.
  • The increasing livestock count and the associated animal feed required for the healthy maintenance of the livestock is likely to advance the expansion of the animal intestinal health market in the North American region.

DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations

Retrieved on: 
Wednesday, September 14, 2022
Biotechnology, Pharmaceutical, Health, CSL, U.S. Securities and Exchange Commission, Inflammation, Outline of health sciences, Employment, Lists of diseases, Chronic kidney disease, COVID-19, Fibrosis, Arthritis, FDA, Nitric oxide, Risk, Hypotension, Nature, Company, MSHS, DMAC, Form 10-K, Hypertension, Stroke, Therapy, Patient, BioCryst Pharmaceuticals, Letter, Dermatology, File, Retinopathy, CEO, Oxidative stress, BS, Terminology, Neurogenesis, Goal, Nasdaq, Private Securities Litigation Reform Act, AIS, Urine, Annual report, CCRP, SVP, KLK1, Vascular dementia, Kidney, George Washington University School of Medicine & Health Sciences, Pharmaceutical industry, Chiltern, Zoology

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Julie VanOrsdel Daves, MSHS, CCRP, as Senior Vice President (SVP), Clinical Development Operations.

Key Points: 
  • DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Julie VanOrsdel Daves, MSHS, CCRP, as Senior Vice President (SVP), Clinical Development Operations.
  • Ms. Daves, a recognized leader in managing global clinical studies, has significant experience in all phases of clinical development and will complement DiaMedicas growing clinical team.
  • Julie brings nearly two decades of clinical development operations experience to DiaMedica across a wide breadth of pharmaceutical therapeutic areas, including Phase 3 pivotal programs.
  • Prior roles include leadership positions in clinical operations at Edgewise Therapeutics, miRagen Therapeutics, Chiltern, Array Biopharma, and BioCryst Pharmaceuticals.

Discover the world’s largest freshwater ecosystem in new TVO Original series Great Lakes Untamed

Retrieved on: 
Tuesday, September 13, 2022
Lynx, Dark, Manufactured Landscapes, Human, Master of Science, Lake, Sea, Merit Motion Pictures, Learning, Junior Ranger Program, BBC, University of Oxford, Earth, BBC Natural History Unit, Rogers, TVO, Mammal, Animal, MMP, Franco-Ontarian, VP, Temperature, Time, France 3, Whale, Manitoba Film and Music, Film, Canada lynx, Life, Mysteries, CBC, History, Science, ISLAND, Natural history, NOVA, Kingdom, YouTube, Canada Media Fund, Association, Anthropocene, Content, GLOBE, Snow, Paddle to the Sea, Silver carp, Terra (mythology), ARTE, Academy, Canadian Wildlife Service, Ice, Smithsonian Channel, National Geographic, Channel, Plant, Education, LTD, Aquaculture, Television, Zoology, Biology, Queen's University

This series will astound viewers with its jaw-dropping imagery and deeply researched revelations about the Great Lakes, says John Ferri, VP of Programming and Content at TVO.

Key Points: 
  • This series will astound viewers with its jaw-dropping imagery and deeply researched revelations about the Great Lakes, says John Ferri, VP of Programming and Content at TVO.
  • Great Lakes Untamed comes at a crucial moment in time, when we have the tools and knowledge to safeguard the future of these lakes and the vast diversity of life that depends on them.
  • TVO Original series Great Lakes Untamed revels in the fascinating history of North Americans five great lakes: Superior, Michigan, Huron, Erie and Ontario.
  • Watch the premiere of episode one of TVO Original series Great Lakes Untamed on Monday, September 26, 2022 at 9 pm ET on TVO, and stream it anytime on TVO Today , YouTube and smart TV services.

Nitrase Therapeutics Appoints Arun Kashyap, Ph.D., to Lead its Recently Launched Oncology Programs as Senior Vice President of Oncology

Retrieved on: 
Wednesday, September 7, 2022
Enzyme, University, CA, Protagonist, Technology, Compugen, Cancer, Cell, Bristol Myers Squibb, Research, Sofinnova, MJFF, Therapy, Developmental Biology (journal), Investment, The Michael J. Fox Foundation, GLOBE, Doctor of Philosophy, University of California, San Francisco, Drug discovery, Industry, Fine chemical, Pharmaceutical industry, Zoology

Dr. Kashyap has more than 25 years of experience as a leading drug discovery and early development expert in the biotherapeutics industry.

Key Points: 
  • Dr. Kashyap has more than 25 years of experience as a leading drug discovery and early development expert in the biotherapeutics industry.
  • He was previously the vice president of research at Arch Oncology where he directed the strategy and operations of discovery and preclinical drug development.
  • Dr. Kashyap added, I am delighted and excited to join Nitrase Therapeutics to lead its oncology efforts.
  • Irene Griswold-Prenner, Ph.D., founder and chief scientific officer of Nitrase Therapeutics, added, I am thrilled to have Aruns expertise on our scientific leadership team.

Scholastic Names Jeffrey Mathews Executive Vice President, Corporate Development and Investor Relations

Retrieved on: 
Tuesday, September 6, 2022
Princeton University, Partnership, Technology, NASDAQ, Strategic management, Publishing, Business development, Book, Literacy, Corporate development, Learning, Investor relations, Scholastic Corporation, Principal, Curriculum, Education, Multimedia, Company, University of Oxford, Growth, Management, Public relations, Zoology, Biology, Scholastic

NEW YORK, Sept. 6, 2022 /PRNewswire/ -- Scholastic (NASDAQ: SCHL), the global children's publishing, education and media company, today announced Jeffrey Mathews has been named Executive Vice President, Corporate Development and Investor Relations.

Key Points: 
  • NEW YORK, Sept. 6, 2022 /PRNewswire/ -- Scholastic (NASDAQ: SCHL), the global children's publishing, education and media company, today announced Jeffrey Mathews has been named Executive Vice President, Corporate Development and Investor Relations.
  • Effective immediately, Mr. Mathews will report to Scholastic President and CEO Peter Warwick in New York.
  • Most recently, Mr. Mathews was Managing Partner at Gagnier Communications, a boutique strategic financial communications and investor relations agency serving clients across North America, Asia and Europe.
  • From 2008 to 2012 at Scholastic, he held the role of Vice President, Corporate Strategy, Business Development & Investor Relations, after four years as head of investor relations for the Company.

Olink strengthens management team for continued leadership in the modern proteomics era

Retrieved on: 
Wednesday, August 31, 2022
COO, Technology, Strategic planning, CEO, Brockport, New York, State university system, Medtech, Molecular Biotechnology, Uppsala University, General officer, George Washington University, St. Jude Medical, PerkinElmer, Zoology, PEA, GLOBE, Leadership, Biology, General manager, Company, Agilent Technologies, CCO, Growth, Master of Science, Discovery, Proteomics, Marketing, State University of New York College of Environmental Science and Forestry, Autocar Sales and Service Building, Management, Galderma, Science

UPPSALA, Sweden, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced several appointments in its leadership structure.

Key Points: 
  • UPPSALA, Sweden, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Olink) (Nasdaq: OLK) today announced several appointments in its leadership structure.
  • Fredriks innovative and proactive execution of supply chain management during unprecedented times has enabled Olink to grow and execute on our plan, said Jon Heimer, CEO of Olink.
  • Todays leadership announcements are a natural evolution of Olink as we mature and position ourselves for sustained growth and long-term market leadership.
  • I am truly grateful and excited to be part of the Olink team as we lead a flourishing and largely untapped market for modern proteomics and protein measurement.

Sportsman's Warehouse Holdings, Inc. Appoints Nancy A. Walsh to Its Board of Directors

Retrieved on: 
Monday, August 22, 2022
Phrase, University, COVID-19, Securities Exchange Act of 1934, NYSE, Securities Act of 1933, LL Flooring, Government, Tapestry, Inc., Warehouse, Schneider, Sale, Board, Executive, Audit committee, Investor relations, Senior, Firearm, SEC, Financial compensation, MBA, GLOBE, Sportsman's Warehouse, Leadership, Board of directors, Company, Chairperson, III, Tapestry, LL, Coach New York, Growth, Private Securities Litigation Reform Act, Forward-looking statement, Family, Management, Zoology, Finance, Director, Northeastern University

WEST JORDAN, Utah, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's Warehouse" or the “Company”) (Nasdaq: SPWH) announced today that Nancy A. Walsh has been appointed to the Company’s Board of Directors, effective August 19, 2022. Ms. Walsh will serve as an independent Class III director. She will serve as a member of the Audit Committee and Compensation Committee of the Board of Directors.

Key Points: 
  • She will serve as a member of the Audit Committee and Compensation Committee of the Board of Directors.
  • Mr. Eastland had served as a member of the Board of Directors for 13 years, and previously served as Chairperson of the Board from 2010 to 2019.
  • Joseph Schneider, Chairman of the Board of Directors, stated, We are pleased to welcome Nancy to our Board of Directors.
  • Her broad financial leadership and experience in the retail space is a valued addition to our Board of Directors.